Post-Injectable Cabotegravir Antiretroviral Salvage Strategy Options Trial
Post-Injectable Cabotegravir Antiretroviral Salvage Strategy Options Trial
Recruiting · NCT06485154 · Registry updated 2026-06-09Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Post-Injectable Cabotegravir Antiretroviral Salvage Strategy Options Trial | HIV Prevention | Recruiting | Phase 4 | 2026-06-09 | NCT06485154 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Bill and Melinda Gates Foundation | 67 |
| University of Witwatersrand, South Africa | 25 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Africa Health Research Institute (AHRI) | Durban | South Africa | 1 |
| Desmond Tutu Health Foundation | Cape Town | South Africa | 1 |
| Ezintsha, a division of Wits Health Consortium | Johannesburg | South Africa | 2 |